Venrock Adviser, LLC Diversified Active

Name: Venrock Adviser, LLC Q2 2026 13F Filing | 13F Explorer
Creator: Venrock Adviser, LLC
Published: 2026-08-14

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $3.298B (100.0% shares, 0.0% debt)

Holdings (33)

New Positions (4)

ACHV ACHIEVE LIFE SCIENCE INC 0.5%

Value $17.96M Shares 2,751,032 Est. Cost — Unrealized —

PBLS PARABILIS MEDICINES INC 0.5%

Value $17.11M Shares 625,000 Est. Cost — Unrealized —

RACC RESEARCH ALLIANCE CORP III 0.1%

Value $3.21M Shares 300,000 Est. Cost — Unrealized —

INM INMED PHARMACEUTICALS INC 0.0%

Value $50,662 Shares 32,685 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACHV	ACHIEVE LIFE SCIENCE INC	2,751,032	$17.96M	0.5%	—	—	COM	004468500
PBLS	PARABILIS MEDICINES INC	625,000	$17.11M	0.5%	—	—	COM	698955101
RACC	RESEARCH ALLIANCE CORP III	300,000	$3.21M	0.1%	—	—	ORD SHS CL A	G75226103
INM	INMED PHARMACEUTICALS INC	32,685	$50,662	0.0%	—	—	COM NEW	457637700

Increased Positions (5)

ERAS ERASCA INC 9.9%

Value $328M (+23.7%) Shares 17,891,812 (+9.2%) Est. Cost — Unrealized —

SVRA SAVARA INC 2.8%

Value $90.84M (+21.1%) Shares 14,745,943 (+7.3%) Est. Cost — Unrealized —

RLMD RELMADA THERAPEUTICS INC 1.4%

Value $47.36M (+40.5%) Shares 6,844,305 (+41.3%) Est. Cost — Unrealized —

ARTV ARTIVA BIOTHERAPEUTICS INC 0.6%

Value $19.82M (+91.2%) Shares 2,043,596 (+27.0%) Est. Cost — Unrealized —

XFOR X4 PHARMACEUTICALS INC 0.3%

Value $9.033M (+561.7%) Shares 1,934,253 (+485.2%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ERAS	ERASCA INC	17,891,812 (+9.2%)	$328M (+23.7%)	9.9%	—	—	COM	29479A108
SVRA	SAVARA INC	14,745,943 (+7.3%)	$90.84M (+21.1%)	2.8%	—	—	COM	805111101
RLMD	RELMADA THERAPEUTICS INC	6,844,305 (+41.3%)	$47.36M (+40.5%)	1.4%	—	—	COM	75955J402
ARTV	ARTIVA BIOTHERAPEUTICS INC	2,043,596 (+27.0%)	$19.82M (+91.2%)	0.6%	—	—	COM	04317A107
XFOR	X4 PHARMACEUTICALS INC	1,934,253 (+485.2%)	$9.033M (+561.7%)	0.3%	—	—	COM NEW	98420X202

Exited Positions (4)

KALV KALVISTA PHARMACEUTICALS INC 4.0%

Value $130M Shares 6,474,485 Est. Cost — Unrealized —

ENGN ENGENE HOLDINGS INC 1.0%

Value $32.49M Shares 4,771,414 Est. Cost — Unrealized —

TENX TENAX THERAPEUTICS INC 0.8%

Value $26.79M Shares 1,675,262 Est. Cost — Unrealized —

SEPN SEPTERNA INC 0.4%

Value $12.16M Shares 506,056 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KALV	KALVISTA PHARMACEUTICALS INC	6,474,485	$130M	4.0%	—	—	—	483497103
ENGN	ENGENE HOLDINGS INC	4,771,414	$32.49M	1.0%	—	—	—	29286M105
TENX	TENAX THERAPEUTICS INC	1,675,262	$26.79M	0.8%	—	—	—	88032L605
SEPN	SEPTERNA INC	506,056	$12.16M	0.4%	—	—	—	81734D104

Decreased Positions (5)

SYRE SPYRE THERAPEUTICS INC 8.0%

Value $265M (+42.6%) Shares 2,985,448 (-19.0%) Est. Cost — Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 0.8%

Value $26.71M (-60.5%) Shares 526,331 (-69.5%) Est. Cost — Unrealized —

CTMX CYTOMX THERAPEUTICS INC 0.6%

Value $18.68M (-60.2%) Shares 4,982,124 (-50.1%) Est. Cost — Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 1.8%

Value $59.85M (-21.2%) Shares 3,257,917 (-16.1%) Est. Cost — Unrealized —

COGT COGENT BIOSCIENCES INC 1.9%

Value $63.55M (-17.4%) Shares 1,642,166 (-17.9%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SYRE	SPYRE THERAPEUTICS INC	2,985,448 (-19.0%)	$265M (+42.6%)	8.0%	—	—	COM NEW	00773J202
ELVN	ENLIVEN THERAPEUTICS INC	526,331 (-69.5%)	$26.71M (-60.5%)	0.8%	—	—	COM	29337E102
CTMX	CYTOMX THERAPEUTICS INC	4,982,124 (-50.1%)	$18.68M (-60.2%)	0.6%	—	—	COM	23284F105
VRDN	VIRIDIAN THERAPEUTICS INC	3,257,917 (-16.1%)	$59.85M (-21.2%)	1.8%	—	—	COM	92790C104
COGT	COGENT BIOSCIENCES INC	1,642,166 (-17.9%)	$63.55M (-17.4%)	1.9%	—	—	COM	19240Q201

Unchanged Positions (19)

APGE APOGEE THERAPEUTICS INC 34.2%

Value $1.127B Shares 8,493,321 Est. Cost — Unrealized —

ORKA ORUKA THERAPEUTICS INC 12.0%

Value $395M Shares 4,148,428 Est. Cost — Unrealized —

JBIO JADE BIOSCIENCES INC 2.2%

Value $71.56M Shares 3,220,364 Est. Cost — Unrealized —

DNTH DIANTHUS THERAPEUTICS INC 3.5%

Value $115M Shares 1,180,000 Est. Cost — Unrealized —

ANL ADLAI NORTYE LTD 1.1%

Value $36.95M Shares 3,212,731 Est. Cost — Unrealized —

OCUL OCULAR THERAPEUTIX INC 3.1%

Value $102M Shares 10,346,926 Est. Cost — Unrealized —

DYN DYNE THERAPEUTICS INC 1.5%

Value $48.28M Shares 2,173,913 Est. Cost — Unrealized —

ORIC ORIC PHARMACEUTICALS INC 1.4%

Value $46.78M Shares 4,319,765 Est. Cost — Unrealized —

HELP CYBIN INC 0.8%

Value $25.46M Shares 3,851,654 Est. Cost — Unrealized —

CGEM CULLINAN THERAPEUTICS INC 0.8%

Value $25.13M Shares 1,379,965 Est. Cost — Unrealized —

SRZN SURROZEN INC 0.5%

Value $16.42M Shares 632,931 Est. Cost — Unrealized —

ANRO ALTO NEUROSCIENCE INC 0.4%

Value $13.2M Shares 500,000 Est. Cost — Unrealized —

KRRO KORRO BIO INC 0.4%

Value $13.31M Shares 1,009,500 Est. Cost — Unrealized —

VOR VOR BIOPHARMA INC 1.7%

Value $56M Shares 3,041,719 Est. Cost — Unrealized —

IPSC CENTURY THERAPEUTICS INC 0.6%

Value $21.3M Shares 8,695,652 Est. Cost — Unrealized —

CBIO CRESCENT BIOPHARMA INC. 1.2%

Value $38.4M Shares 2,133,576 Est. Cost — Unrealized —

GLTO DAMORA THERAPEUTICS INC 2.8%

Value $93.73M Shares 3,603,595 Est. Cost — Unrealized —

ZURA ZURA BIO LTD 1.2%

Value $37.97M Shares 6,434,990 Est. Cost — Unrealized —

MAZE MAZE THERAPEUTICS INC 1.4%

Value $47.8M Shares 1,602,034 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
APGE	APOGEE THERAPEUTICS INC	8,493,321	$1.127B	34.2%	—	—	COM	03770N101
ORKA	ORUKA THERAPEUTICS INC	4,148,428	$395M	12.0%	—	—	COM	687604108
JBIO	JADE BIOSCIENCES INC	3,220,364	$71.56M	2.2%	—	—	COM NEW	008064206
DNTH	DIANTHUS THERAPEUTICS INC	1,180,000	$115M	3.5%	—	—	COM	252828108
ANL	ADLAI NORTYE LTD	3,212,731	$36.95M	1.1%	—	—	SPONSORED ADS	00704R109
OCUL	OCULAR THERAPEUTIX INC	10,346,926	$102M	3.1%	—	—	COM	67576A100
DYN	DYNE THERAPEUTICS INC	2,173,913	$48.28M	1.5%	—	—	COM	26818M108
ORIC	ORIC PHARMACEUTICALS INC	4,319,765	$46.78M	1.4%	—	—	COM	68622P109
HELP	CYBIN INC	3,851,654	$25.46M	0.8%	—	—	COM NEW	23256X407
CGEM	CULLINAN THERAPEUTICS INC	1,379,965	$25.13M	0.8%	—	—	COM	230031106
SRZN	SURROZEN INC	632,931	$16.42M	0.5%	—	—	COM NEW	86889P208
ANRO	ALTO NEUROSCIENCE INC	500,000	$13.2M	0.4%	—	—	COM SHS	02157Q109
KRRO	KORRO BIO INC	1,009,500	$13.31M	0.4%	—	—	COM	500946108
VOR	VOR BIOPHARMA INC	3,041,719	$56M	1.7%	—	—	COM NEW	929033207
IPSC	CENTURY THERAPEUTICS INC	8,695,652	$21.3M	0.6%	—	—	COM	15673T100
CBIO	CRESCENT BIOPHARMA INC.	2,133,576	$38.4M	1.2%	—	—	COM	G2545C104
GLTO	DAMORA THERAPEUTICS INC	3,603,595	$93.73M	2.8%	—	—	COM NEW	36322Q206
ZURA	ZURA BIO LTD	6,434,990	$37.97M	1.2%	—	—	CLASS A ORD SHS	G9TY5A101
MAZE	MAZE THERAPEUTICS INC	1,602,034	$47.8M	1.4%	—	—	COM	578784100